XOMA to Host Conference Call to Present Initial Results From XOMA 052 Clinical Trial in Behcet's Disease Jun 10, 2010 5:00pm EDT
Abstract Published on Initial Results From XOMA 052 Clinical Trial in Behcet's Disease May 12, 2010 2:38pm EDT
XOMA 052 Mechanism of Action Results Published in Journal of Biological Chemistry Apr 30, 2010 1:30pm EDT
XOMA to Announce 2010 First Quarter Financial Results and Host Webcast Conference Call on May 6 Apr 29, 2010 6:09pm EDT
XOMA 052 Shows Potent In Vitro Inhibition of Interleukin-6 Production in Human Myeloma Cells Apr 19, 2010 5:27pm EDT
XOMA Issued Two New U.S. Patents for Methods of Treating Type 2 Diabetes and Inflammatory Diseases Using Interleukin-1 Beta Antibodies Apr 13, 2010 6:00am EDT
Data on XOMA 052 to be Presented at the American Association of Cancer Research Annual Meeting Apr 09, 2010 8:00am EDT
